Warren R, Sofen H, Imafuku S, Szepietowski J, Blauvelt A, Spelman L, Toms J, Buck A, Banerjee S, Menter A. Deucravacitinib long-term efficacy and safety in plaque psoriasis: 2-year results from the phase 3 POETYK PSO program. J of Skin [Internet]. 2022Nov.16 [cited 2024Jul.3];6(6):s48. Available from: https://jofskin.org/index.php/skin/article/view/1803